geminismith

Главная

Reels

Мероприятия

Найти Мероприятия Мои события

Статьи пользователей

Найти Статьи пользователей Статьи пользователей

Маркет

Найти Маркет Мои товары

Группы

Найти Группы Мои группы

Страницы

Найти Страницы Понравились страницы

Ещё

Популярные записи Найти сообщения Funding My Funding Offers Создать страницу Jobs Список групп Courses Категории Форумы Кинозал Игры Разработчики Merits

Entreprises locales

Runsound music

La silver économie

Affiliation Matrice 3x9

Récompenses

Babarun (BBRN)

Calculez vos calories

Collab Influenceurs

Événementiels

Procaly

Affiliation

Prêts Immobiliers

Маркет Статьи пользователей Страницы Группы

Мероприятия Jobs Offers

Entreprises locales

Runsound music

La silver économie

Affiliation Matrice 3x9

Récompenses

Babarun (BBRN)

Calculez vos calories

Collab Influenceurs

Événementiels

Procaly

Affiliation

Prêts Immobiliers Смотреть все

Обновить до Про

geminismith

Influenceurs & Créateurs de contenu

@geminismith

О нас

26 Записей

1 Фото

0 Видео

1 в 1

Проживает в Shirley, NY, USA

Из New York, NY, USA

Образование 1 в Shirley

Class of 1

20/08/2000

Читают 0 человек

Фото

geminismith добавлена новая статья Technologies

2026-01-20 05:37:30 ·Перевод ·

The Cell's Uninvited Guest: Mastering the Art of Molecular Breaking and Entering

For decades, the biggest challenge in medicine wasn't just finding a drug that worked—it was getting that drug to the right "address" without destroying everything else along the way. Traditional chemotherapy, for instance, is often compared to carpet bombing: it kills the enemy, but it also devastates the surrounding city. As we move through 2026, a quiet revolution in Targeted...

·641 Просмотры ·0 предпросмотр

Войдите, чтобы отмечать, делиться и комментировать!
geminismith добавлена новая статья Science

2026-01-20 05:35:26 ·Перевод ·

Exploring B-Cell Isolation Workflows to Enhance Therapeutic Antibody Screening

In modern therapeutic antibody development, the ability to isolate naturally paired heavy and light chain antibody sequences from B cells is a decisive factor in generating fully human, high-affinity monoclonal antibodies (mAbs). Researchers now rely on innovative B-cell sorting workflows that combine precision, efficiency, and biological relevance. Among the most widely used strategies are...

·661 Просмотры ·0 предпросмотр

Войдите, чтобы отмечать, делиться и комментировать!
geminismith добавлена новая статья Technologies

2026-01-20 05:30:23 ·Перевод ·

When Two Amino Acids Look the Same but Act Differently

In the rapidly evolving field of protein and antibody analysis, achieving exceptional sequence precision is more important than ever. With advances in mass spectrometry and data analytics, the realm of de novo sequencing has experienced pivotal breakthroughs—especially when it comes to the challenge of distinguishing so-called "ambiguous" amino acids. Today we'll explore how...

·570 Просмотры ·0 предпросмотр

Войдите, чтобы отмечать, делиться и комментировать!
geminismith добавлена новая статья Technologies

2026-01-20 03:49:59 ·Перевод ·

Inside the Immune Battlefield: How Engineered Viruses Help Win the War on Cancer

In the rapidly evolving landscape of cancer immunotherapy, oncolytic virotherapy has emerged as a dynamic force capable of amplifying the immune response against tumors. Once seen merely as a means of direct tumor lysis, oncolytic viruses (OVs) are now recognized for their ability to reshape the tumor microenvironment, recruit immune cells, and enhance the effectiveness of existing therapeutic...

·807 Просмотры ·0 предпросмотр

Войдите, чтобы отмечать, делиться и комментировать!
geminismith добавлена новая статья Science

2026-01-20 03:44:41 ·Перевод ·

Redesigning the Rules of Drug Discovery Through Protein Degradation

The rise of targeted protein degradation (TPD) has opened a new chapter in modern drug discovery. Unlike traditional inhibitors that merely block protein activity, degraders work by eliminating disease-causing proteins altogether through the ubiquitin–proteasome system. Behind this elegant mechanism lies a delicate balance between three essential components — linkers, ligands, and...

·630 Просмотры ·0 предпросмотр

Войдите, чтобы отмечать, делиться и комментировать!
geminismith добавлена новая статья Technologies

2025-12-17 07:51:38 ·Перевод ·

The Quiet Revolution: How AI-Driven Antibody Engineering Is Rewriting Biotherapeutic Discovery

The biopharmaceutical industry is going through a silent but profound transformation. While headlines tend to focus on blockbuster drugs or billion-dollar mergers, another movement is gathering momentum beneath the surface—one powered not by laboratory throughput alone, but by algorithmic intelligence. Antibody engineering, once defined by trial-and-error approaches and lengthy...

·787 Просмотры ·0 предпросмотр

Войдите, чтобы отмечать, делиться и комментировать!
geminismith добавлена новая статья Technologies

2025-12-17 07:46:17 ·Перевод ·

From RA to Asthma: Preclinical Models Shaping the Future of Immunotherapy

The pharmaceutical landscape is entering a phase of unprecedented focus on immune-mediated diseases, with research teams racing to develop treatments for conditions ranging from autoimmune disorders to chronic inflammatory diseases. The key to this progress is not just advanced molecular tools—it is also the strategic use of robust preclinical disease models that faithfully recapitulate...

·1Кб Просмотры ·0 предпросмотр

Войдите, чтобы отмечать, делиться и комментировать!
geminismith добавлена новая статья Technologies

2025-12-17 07:42:15 ·Перевод ·

The Rising Demand for High-Potency ADC Payloads: Why the Supply Chain Is Being Reshaped in 2025

Antibody–drug conjugates (ADCs) continue to reshape the oncology pipeline, driven by the pursuit of payloads that can deliver stronger potency, improved tumor selectivity, and reduced systemic toxicity. Although more than a decade has passed since the approval of the first ADC, payload development remains one of the fastest-moving components of the field. With growing interest in high-DAR...

·931 Просмотры ·0 предпросмотр

Войдите, чтобы отмечать, делиться и комментировать!
geminismith добавлена новая статья Technologies

2025-12-17 07:39:01 ·Перевод ·

Riding the Non-IgG Wave: Why Researchers Are Turning to Alternative Immunoglobulins

For years, the life sciences community has focused its attention—and budgets—on IgG antibodies. They were the gold standard for therapeutic development, biomarker screening, and diagnostic innovation. But as biological questions grow more complex and precision medicine becomes increasingly nuanced, a new trend has emerged: a surge of interest in non-IgG antibodies and proteins....

·904 Просмотры ·0 предпросмотр

Войдите, чтобы отмечать, делиться и комментировать!
geminismith добавлена новая статья Technologies

2025-12-17 07:37:15 ·Перевод ·

Best Immunoassay Kit Development Technologies for Modern Diagnostics

In vitro diagnostics (IVD) have become the cornerstone of modern medical decision-making. Among the vast array of analytical technologies, immunoassays stand out for their high specificity, sensitivity, and adaptability. Over the past few decades, continuous technological refinement—from colorimetric to chemiluminescent detection—has redefined how clinicians and researchers...

·1Кб Просмотры ·0 предпросмотр

Войдите, чтобы отмечать, делиться и комментировать!
geminismith добавлена новая статья Technologies

2025-11-11 07:56:54 ·Перевод ·

Two Primates One Goal Transforming Preclinical Success into Clinical Reality

Translational research depends on reliable animal models that can accurately mimic human biology. Among all preclinical options, non-human primates (NHPs) stand out for their close genetic, immunological, and physiological similarity to humans. Two key NHP species—the Cynomolgus Monkey and the Marmoset—have become indispensable in bridging the gap between discovery and clinical...

·838 Просмотры ·0 предпросмотр

Войдите, чтобы отмечать, делиться и комментировать!
geminismith добавлена новая статья Science

2025-11-11 07:50:51 ·Перевод ·

Bispecific Antibody Platforms and Target-Based Design: The Key to Next-Generation Therapeutics

In the rapidly evolving field of antibody therapeutics, bispecific antibodies (BsAbs) are gaining momentum thanks to their ability to engage two distinct targets simultaneously. One critical application lies in developing molecules that specifically interfere with receptor-mediated signalling. For example, when a BsAb is engineered for bispecific receptor binding, it can simultaneously target...

·1Кб Просмотры ·0 предпросмотр

Войдите, чтобы отмечать, делиться и комментировать!

Больше

Babafig https://www.babafig.com

Вступить

Языки

geminismith

Influenceurs & Créateurs de contenu

The Cell's Uninvited Guest: Mastering the Art of Molecular Breaking and Entering

Exploring B-Cell Isolation Workflows to Enhance Therapeutic Antibody Screening

When Two Amino Acids Look the Same but Act Differently

Inside the Immune Battlefield: How Engineered Viruses Help Win the War on Cancer

Redesigning the Rules of Drug Discovery Through Protein Degradation

The Quiet Revolution: How AI-Driven Antibody Engineering Is Rewriting Biotherapeutic Discovery

From RA to Asthma: Preclinical Models Shaping the Future of Immunotherapy

The Rising Demand for High-Potency ADC Payloads: Why the Supply Chain Is Being Reshaped in 2025

Riding the Non-IgG Wave: Why Researchers Are Turning to Alternative Immunoglobulins

Best Immunoassay Kit Development Technologies for Modern Diagnostics

Two Primates One Goal Transforming Preclinical Success into Clinical Reality

Bispecific Antibody Platforms and Target-Based Design: The Key to Next-Generation Therapeutics